|
Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
ISSN: 1596-5996 EISSN: 1596-5996
Vol. 13, No. 9, 2014, pp. 1545-1548
|
Bioline Code: pr14212
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Tropical Journal of Pharmaceutical Research, Vol. 13, No. 9, 2014, pp. 1545-1548
en |
A Study of the Association of Polymorphism rs5860110 and its Protective Role against Ankylosing Spondylitis in a Chinese Population
Wang, Xiufang & Zhang, Zhaoqing
Abstract
Purpose: To investigate whether secreted phosphoprotein-1(SPP1) promoter variants are
associated with susceptibility to ankylosing spondylitis (AS) in the western China. Methods: The rs5860110 variant of SPP1 promoter was genotyped using direct sequencing in 120
unrelated AS patients and 106 ethnically matched healthy controls. All the patients were human
leukocyte antigen (HLA)-B27 positive. Frequencies of different genotypes and alleles were analyzed
among the AS patients and the controls. Results: In AS patient group, frequency of +254 SPP1 promoter genotype was 0.483 in base TG/TG
homozygotes and 0.517 in TG-(deletion)/TG-(deletion) homozygotes, while the values for the control
group were 0.311 and 0.689, respectively. However, TG-(deletion)/TG heterozygote was not detected in
this study. The rs5860110 single nucleotide polymorphism (SNP) in SPP1 was significantly different
when all AS patients were compared to controls (p < 0.01). Conclusion: The rs5860110 SNP in SPP1 has a protective role against AS in the selected Chinese
population.
Keywords
Polymorphism; Ankylosing spondylitis; Secreted phosphoprotein-1; Sequencing; Genotype; Alleles
|
|
© Copyright 2014 - Tropical Journal of Pharmaceutical Research Alternative site location: http://www.tjpr.org
|
|